Advances in Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing

Download All
Gain insights into the latest advances in NTRK fusion testing and recent advances in tumor-agnostic TRK inhibition through expert-guided discussion.
George D. Demetri, MD
Program Director
Alexander Drilon, MD
Pashtoon M. Kasi, MD, MS

On-Demand Video Webcast

Watch this interactive, on-demand Webcast led by George D. Demetri, MD, and featuring an expert panel discussing best practices in testing for NTRK fusions in solid tumors, current evidence supporting the use of approved TRK inhibitors, and emerging topics, including TRK inhibitor resistance and second-generation agents.

George D. Demetri, MD
Program Director
Alexander Drilon, MD Pashtoon M. Kasi, MD, MS
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 21, 2020 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings